
Pharma giants pull back on AAV research: what’s next for the gene therapy space?
Newsletter Signup - Under Article / In Page "*" indicates required fields Once hailed as the solution to delivering gene therapies, adeno-associated virus (AAV) vectors have seen their star dim in recent years. Initially touted for its …